Top Markets
#1 Black Phoenix Black Phoenix +354.53%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.04%
#4 Akedo Akedo +52.53%
#5 Acurast Acurast +32.15%
#6 BasedHype BasedHype +28.07%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.45%
#9 Avantis Avantis +18.91%
#10 HOME HOME +14.70%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
株式のランク #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
株価
$0.02765
最終同期: 2024-12-23
時価総額
$69.04K
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Histogen Inc. (HSTO)

カテゴリー

Healthcare
Histogen Inc.（HSTO）の発行済株式数
September 2023 時点の発行済株式数 4.27M
Histogen Inc. の最新の財務報告および株価によると、現在の発行済株式数は 4.27M です。December 2021 の終わりには、同社は 1.92M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Histogen Inc.（HSTO）の発行済株式数の履歴（2011 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 4.27M 33.04%
2022 3.21M 67.41%
2021 1.92M 325.35%
2020 450.92K -23.66%
2019 590.69K 289.00%
2018 151.85K 6.24%
2017 142.93K 26.21%
2016 113.25K -99.39%
2015 18.62M 20.28%
2014 15.48M 110.37%
2013 7.36M 15,800.25%
2012 46.28K 0.00%
2011 46.28K 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,843.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,355.65%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE